Moreover, the levels of CD4 and CD8 positive cells in tumor tissues were notably elevated by overexpression of METTL16 and anti-PD-1 treatment compared with the control group and were further increased by their combination (Figure 6D). The gene discussed is METTL16; the disease is neoplasm.